ReviewClujul medical (1957)2016

The cardiovascular impact of visfatin - an inflammation predictor biomarker in metabolic syndrome.

Larisa Diana Mocan Hognogi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.